Page 4 - Alexis Borisy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alexis borisy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alexis Borisy Today - Breaking & Trending Today

SVB Securities Downgrades Blueprint Medicines (NASDAQ:BPMC) to Underperform

SVB Securities downgraded shares of Blueprint Medicines (NASDAQ:BPMC – Get Rating) from a market perform rating to an underperform rating in a research note issued to investors on Monday morning, The Fly reports. They currently have $43.00 target price on the biotechnology company’s stock, down from their prior target price of $48.00. Other analysts have […] ....

United Kingdom , United Kingdom General , Raymond James , Brian Druker , Nicholasb Lydon , Percyh Carter , Chris Varma , Blueprint Medicines Corp , Blackrock Inc , Raymond James Associates , Us Bancorp , Blueprint Medicines Company Profile , Metlife Investment Management , Blueprint Medicines , Get Rating , Life Investment Management , Alexis Borisy , Blueprint Medicines Daily , Nasdaq Bpmc , Svb Securities ,

Blueprint Medicines Co. (NASDAQ:BPMC) Insider Percy H. Carter Sells 2,307 Shares

Blueprint Medicines Co. (NASDAQ:BPMC – Get Rating) insider Percy H. Carter sold 2,307 shares of the stock in a transaction that occurred on Monday, June 5th. The shares were sold at an average price of $52.06, for a total value of $120,102.42. Following the transaction, the insider now directly owns 38,117 shares of the company’s […] ....

United Kingdom General , United Kingdom , Nicholasb Lydon , Brian Druker , Chris Varma , Percyh Carter , Needham Company , Norges Bank , Blackrock Inc , Pricet Rowe Associates Inc , Securities Exchange Commission , Blueprint Medicines Corp , Marshall Wace , Blueprint Medicines Co , Blueprint Medicines , Get Rating , Exchange Commission , Street Corp , Alexis Borisy , Blueprint Medicines Daily , Nasdaq Bpmc , Insider Trading , Nsider Trades ,

Blueprint Medicines (NASDAQ:BPMC) Downgraded by SVB Leerink

SVB Leerink lowered shares of Blueprint Medicines (NASDAQ:BPMC – Get Rating) from a market perform rating to an underperform rating in a report published on Monday, PriceTargets.com reports. A number of other research firms also recently weighed in on BPMC. Raymond James dropped their target price on Blueprint Medicines from $115.00 to $85.00 and set […] ....

United Kingdom , Brian Druker , Raymond James , Percyh Carter , Nicholasb Lydon , Chris Varma , Corton Capital Inc , Blueprint Medicines Company Profile , Associates Corp , Blueprint Medicines Corp , Needham Company , Fund Management Co , Securities Exchange Commission , Blueprint Medicines , Get Rating , Exchange Commission , Fund Management , Alexis Borisy , Blueprint Medicines Daily , Nasdaq Bpmc , Svb Leerink Llc ,

Blueprint Medicines (NASDAQ:BPMC) Shares Down 5.9% After Insider Selling

Blueprint Medicines Co. (NASDAQ:BPMC – Get Rating) shares traded down 5.9% on Thursday following insider selling activity. The stock traded as low as $56.44 and last traded at $56.48. 317,027 shares changed hands during mid-day trading, a decline of 45% from the average session volume of 581,232 shares. The stock had previously closed at $60.03. […] ....

United Kingdom General , United Kingdom , Raymond James , Percyh Carter , Chris Varma , Nicholasb Lydon , Brian Druker , Blueprint Medicines Company Profile , Blackrock Inc , Marshall Wace , Norges Bank , Blueprint Medicines Co , Pricet Rowe Associates Inc , Blueprint Medicines Corp , Blueprint Medicines , Get Rating , Medicines Stock Down , Street Corp , Alexis Borisy , Blueprint Medicines Daily , Nasdaq Bpmc ,